Lantern Pharma Yönetim
Yönetim kriter kontrolleri 4/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Panna Sharma
İcra Kurulu Başkanı
US$684.4k
Toplam tazminat
CEO maaş yüzdesi | 76.8% |
CEO görev süresi | 6.3yrs |
CEO sahipliği | n/a |
Yönetim ortalama görev süresi | 4.9yrs |
Yönetim Kurulu ortalama görev süresi | 6.3yrs |
Son yönetim güncellemeleri
Recent updates
Is Lantern Pharma (NASDAQ:LTRN) In A Good Position To Invest In Growth?
Nov 05Lantern Pharma (NASDAQ:LTRN) Is In A Good Position To Deliver On Growth Plans
Jun 12We're Hopeful That Lantern Pharma (NASDAQ:LTRN) Will Use Its Cash Wisely
Feb 28We're Not Very Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Rate
Nov 06Lantern Pharma (NASDAQ:LTRN) Is In A Good Position To Deliver On Growth Plans
Jul 20We're Hopeful That Lantern Pharma (NASDAQ:LTRN) Will Use Its Cash Wisely
Apr 04Here's Why We're Not Too Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Situation
Dec 19We're Hopeful That Lantern Pharma (NASDAQ:LTRN) Will Use Its Cash Wisely
Sep 02Lantern Pharma gets FDA nod to start mid-stage study of LP-300 in lung cancer
Jul 14Companies Like Lantern Pharma (NASDAQ:LTRN) Are In A Position To Invest In Growth
May 20Here's Why We're Not Too Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Situation
Feb 02We're Hopeful That Lantern Pharma (NASDAQ:LTRN) Will Use Its Cash Wisely
Oct 13Lantern Pharma: Consider A Speculative Long-Term Investment In This AI Drug Discoverer
Aug 24Lantern Pharma: Drug Recycling With AI
Jun 08We're Not Very Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Rate
May 05Lantern Pharma reports Q1 results
May 03Here's What Lantern Pharma Inc.'s (NASDAQ:LTRN) Shareholder Ownership Structure Looks Like
Feb 19Lantern Pharma announces antibody drug conjugate tie-up with Califia Pharma
Jan 04Who Has Been Buying Lantern Pharma Inc. (NASDAQ:LTRN) Shares?
Dec 28Lantern: Early Stage 'Smart Drug' Discovery Company
Nov 25CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$18m |
Mar 31 2024 | n/a | n/a | -US$18m |
Dec 31 2023 | US$684k | US$525k | -US$16m |
Sep 30 2023 | n/a | n/a | -US$15m |
Jun 30 2023 | n/a | n/a | -US$14m |
Mar 31 2023 | n/a | n/a | -US$14m |
Dec 31 2022 | US$1m | US$475k | -US$14m |
Sep 30 2022 | n/a | n/a | -US$14m |
Jun 30 2022 | n/a | n/a | -US$16m |
Mar 31 2022 | n/a | n/a | -US$14m |
Dec 31 2021 | US$622k | US$432k | -US$12m |
Sep 30 2021 | n/a | n/a | -US$12m |
Jun 30 2021 | n/a | n/a | -US$9m |
Mar 31 2021 | n/a | n/a | -US$8m |
Dec 31 2020 | US$2m | US$384k | -US$6m |
Sep 30 2020 | n/a | n/a | -US$4m |
Jun 30 2020 | n/a | n/a | -US$3m |
Mar 31 2020 | n/a | n/a | -US$2m |
Dec 31 2019 | US$332k | US$267k | -US$2m |
Dec 31 2018 | US$353k | US$105k | -US$2m |
Tazminat ve Piyasa: Panna 'ın toplam tazminatı ($USD 684.39K ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 653.16K ).
Tazminat ve Kazançlar: Panna 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Panna Sharma (53 yo)
6.3yrs
Görev süresi
US$684,385
Tazminat
Mr. Panna Sharma has been the Chief Executive Officer and President of Lantern Pharma Inc. since July 26, 2018 and has been its Director since August 29, 2018. As Chief Executive Officer, Mr. Sharma overse...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 6.3yrs | US$684.39k | Veri yok | |
CFO & Secretary | 6.4yrs | US$442.68k | Veri yok | |
Chief Scientific Officer & Scientific Consultant | 4.9yrs | US$283.24k | Veri yok | |
Investor Relations Associate | no data | Veri yok | Veri yok | |
Co-Founder & Advisor | no data | US$794.00 | Veri yok | |
Head of Clinical Operations | 1.7yrs | Veri yok | Veri yok | |
Chief Medical Officer of Starlight Therapeutics | less than a year | Veri yok | Veri yok |
4.9yrs
Ortalama Görev Süresi
63yo
Ortalama Yaş
Deneyimli Yönetim: LTRN 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.9 yıldır).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 6.3yrs | US$684.39k | Veri yok | |
Independent Director | 5.1yrs | US$46.00k | Veri yok | |
Independent Director | 2.4yrs | US$51.00k | Veri yok | |
Independent Chairman | 6.8yrs | US$56.00k | 0.39% $ 137.1k | |
Independent Director | 6.4yrs | US$46.00k | Veri yok |
6.3yrs
Ortalama Görev Süresi
71yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: LTRN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.3 yıldır).